Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-039-8 | CAS number: 25322-69-4 1 - 4.5 moles propoxylated
Endpoint summary
Administrative data
Description of key information
NOAEL (28 days repeated dose, Wistar): = 1000 mg/kg bw.
Key value for chemical safety assessment
Additional information
Results 'read across' from study on 2, 2', 2''-nitrilotriethanol, propoxylated, as permitted by Annex XI para 1.5, based on the justification in the report by Paul Illing Consultancy Services Ltd and Marlin Consultancy (Illing and Barratt, 2007, revised 2009). The report identifies that 2, 2', 2''-nitrilotriethanol, propoxylated is the most bioavailable of the NLP polyols linked by an ether group, and the lack of toxicity seen for it should be considered representative of the lack of toxicity of the ether linked polyol. Thus, on animal welfare grounds this test should not be undertaken on propane-1,2-diol, propoxylated. For further details concerning the grouping, consult Illing and Barratt (2007).
In a repeated dose oral toxicity study in rats (Wistar, OECD TG 407), 2,2',2" -Nitrilotriethanol, propoxylated was administered via gavage to 5 rats/sex/dose at 0, 100, 300, 1000 mg/kg bw for 4 weeks. No death was observed in either sex. No clinical effects were observed in both sex of all dose groups. There was no effect observed upon haematological, clinical biochemistry or macroscopic examination at any dose. Based on these results the NOAEL was considered to be = 1000 mg/kg bw/day. If at all the slight changes in thyroids of females at 1000 mg/kg were related to the treatment, they are regarded as an indirect and adaptive effect.
The need for further testing for individual NLP polyols under the REACH Regulation can be significantly modified if arrangements for grouping into categories and ‘read across’, based on the principles in Annex XI can be used. The justifications and the proposed categories are set out in Part 1 of Barratt and Illing (2007). 'Read across' based on (a) the same bond linking the core moiety and the repeating unit moiety (b) molecular weight distributions. Experimental data on core substances, repeating units, selected polyols within the category and 'read across' based on bioavailabilities indicates that the propoxylated substances in this category are not classifiable in respect of their repeated dose toxicity. This categorisation for read across has also been used to justify read across for tests required by Annex VII and VIII. There is sufficient available information for an adequate hazard characterisation and a chemical safety assessment. In view of this ‘weight of evidence’ approach and the need to consider animal welfare, no further testing is proposed.
Justification for classification or non-classification
On the basis of 'read across' the substance does not meet the criteria for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
